Crossmark

A drug repurposing endeavor to discover a multi-targeting ligand against RhlR and LasR proteins from opportunistic human pathogen Pseudomonas aeruginosa

Crossref DOI link: https://doi.org/10.1007/s00894-022-05301-w

Published Online: 2022-09-05

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chowdhury, Nilkanta

Bagchi, Angshuman
Funding

Funding for this research was provided by:

Indian Council of Medical Research (BIC/12(02)/2014)
License Information

Text and Data Mining valid from 2022-09-05

Version of Record valid from 2022-09-05
More Information

Article History

Received: 20 September 2021

Accepted: 29 August 2022

First Online: 5 September 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below